Acessibilidade / Reportar erro

Authors' reply

Spontaneous abortion is the most frequent adverse outcome in pregnancy, with a rate of 10% to 20% of all pregnancies. In Brazil, the rate of abortion before the COVID-19 pandemic was of 3.5%. In our study, we observed 24 miscarriages after 678,025 doses of COVID-19 vaccines had been administered in pregnant women in Brazil, which corresponds to an incidence of 3.5 cases per 100,000 doses.11 Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017;1(01):CD007223Doi: 10.1002/14651858.CD007223.pub4
https://doi.org/10.1002/14651858.CD00722...
Such incidence is lower than the postvaccination rate of abortion related to COVID-19 vaccines described by Trostle et al.22 Trostle ME, Limaye MA, Avtushka V, Lighter JL, Penfield CA, Roman AS. COVID-19 vaccination in pregnancy: early experience from a single institution. Am J Obstet Gynecol MFM. 2021;3(06):100464Doi: 10.1016/j.ajogmf.2021.100464
https://doi.org/10.1016/j.ajogmf.2021.10...
and much lower than the historical 3.5% expected rate in Brazil.

Our study was observational and used passive surveillance data. Such studies cannot describe the exact rates of abortion in vaccinated pregnant women. Nonetheless, given the historical rates in Brazil, the expected number of abortions in 678,025 normal pregnancies would be 23,731, which averages out to 616 abortions per week of observation. Even if we consider reporting rates lower than 5%, our incidence of abortions would still be far below the expected.33 Sookaromdee P, Wiwanitkit V. Magnitude of abortion after COVID-19 vaccination: how about rate? Erciyes Med J. 2022;44(02):244Doi: 10.14744/etd.2021.78379
https://doi.org/10.14744/etd.2021.78379...

Currently, the Brazilian Ministry of Health and the Pan American Health Organization (PAHO) are conducting a prospective active surveillance study with women who were vaccinated against COVID-19 during pregnancy in the 5 regions of the country. Such study will enable a more accurate description of the true rates of abortion and other adverse pregnancy outcomes in vaccinated women.

It is already known that pregnant women have a higher risk of developing severe COVID-19 and an increased risk of having adverse maternal and neonatal outcomes after COVID-19. We believe that our data, in association with the previously-published literature, suggests that the benefits of vaccinating pregnant women against COVID-19 far outweighs the risk of the disease.44 Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–2282Doi: 10.1056/NEJMoa2104983
https://doi.org/10.1056/NEJMoa2104983...

References

  • 1
    Kim C, Barnard S, Neilson JP, Hickey M, Vazquez JC, Dou L. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017;1(01):CD007223Doi: 10.1002/14651858.CD007223.pub4
    » https://doi.org/10.1002/14651858.CD007223.pub4
  • 2
    Trostle ME, Limaye MA, Avtushka V, Lighter JL, Penfield CA, Roman AS. COVID-19 vaccination in pregnancy: early experience from a single institution. Am J Obstet Gynecol MFM. 2021;3(06):100464Doi: 10.1016/j.ajogmf.2021.100464
    » https://doi.org/10.1016/j.ajogmf.2021.100464
  • 3
    Sookaromdee P, Wiwanitkit V. Magnitude of abortion after COVID-19 vaccination: how about rate? Erciyes Med J. 2022;44(02):244Doi: 10.14744/etd.2021.78379
    » https://doi.org/10.14744/etd.2021.78379
  • 4
    Shimabukuro TT, Kim SY, Myers TR, Moro PL, Oduyebo T, Panagiotakopoulos L, et al; CDC v-safe COVID-19 Pregnancy Registry Team. Preliminary findings of mRNA Covid-19 vaccine safety in pregnant persons. N Engl J Med. 2021;384(24):2273–2282Doi: 10.1056/NEJMoa2104983
    » https://doi.org/10.1056/NEJMoa2104983

Publication Dates

  • Publication in this collection
    23 Jan 2023
  • Date of issue
    2022
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia Av. Brigadeiro Luís Antônio, 3421, sala 903 - Jardim Paulista, 01401-001 São Paulo SP - Brasil, Tel. (55 11) 5573-4919 - Rio de Janeiro - RJ - Brazil
E-mail: editorial.office@febrasgo.org.br